HARBIN, China, May 20 /PRNewswire-Asia/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that the Company successfully exhibited its unique portfolio of natural products at the 107th China Import and Export Fair ("the Canton Fair") held in Guangzhou, China from May 1 to May 5, 2010.
This year's Canton Fair was well attended by many overseas distributors, with participation reaching levels not seen since the onset of the global economic slowdown. Over 20,000 overseas distributors from more than 200 countries and regions around the world attended the Canton Fair. Total export sales at the 107th Canton Fair exceeded $34.0 billion, up 12.6% from autumn 2009.
Renhuang showcased its Siberian Ginseng (Acanthopanax) products, which have well-documented benefits for treating depression and anxiety without the side effects often associated with chemical-based drugs. Also featured at the Canton Fair was the Company's Shengmai Granules, a leading TCM product for the treatment of hormonal complications in women. These two product lines in particular generated significant interest among international distributors, which may create cooperative opportunities over time.
"Participation at the 107th Canton Fair provided Renhuang with a great platform to exhibit our innovative, all-natural medicines to many distributors from around the world. We continue to seek export opportunities to enhance our growth prospects while strengthening our leadership in the domestic market," said Mr. Shaoming Li, Chairman and Chief Executive Officer of Renhuang. "With depression and anxiety being among the world's leading public health concerns, we anticipate high growth in demand for our safe, all-natural and effective treatments for these conditions."
About China Import and Export Fair
China Import and Export Fair, also known as the Canton Fair, is held twice a year in the spring and autumn since it was inaugurated in 1957. It is China's largest trade fair and the most attended. Preserving its tradition, the Canton Fair is a comprehensive and multi-functional event of international importance. The Canton Fair is co-hosted by the Ministry of Commerce of China and the People's Government of Guangdong Province to help foster the development of China's foreign trade and exchange with the rest of the world. To learn more, please visit http://www.cantonfair.org.cn/en/index.asp .
ABOUT RENHUANG PHARMACEUTICALS, INC.
Renhuang Pharmaceuticals, Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China. Company Website: http://www.renhuang.com .
Safe Harbor Statement
This press release contains certain statements that may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based upon management's beliefs, assumptions and expectations of the Company's future operations and economic performance, taking into account the information currently available to management. These statements are not statements of historical fact. Forward-looking statements involve risks and uncertainties, some of which are not currently known that may cause actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial condition expressed or implied in any forward-looking statements. These forward-looking statements are based on current plans and expectations and are subject to a number of uncertainties including, but not limited to, the Company's participation in the 107th China Import and Export Fair and expected positive outcomes, ability to manage expansion of its operations effectively, and other factors detailed in the Company's annual report on Form 10-K and other filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented herein.
For more information, please contact:
Company Contact:
Renhuang Pharmaceuticals, Inc.
Ms. Portia Tan, IR Contact
Tel: +86-451-5392-5461
Email: ir@renhuang.com
CCG Investor Relations:
Ms. Lei Huang, Account Manager
Tel: +1-646-833-3417 (New York)
Email: lei.huang@ccgir.com
Web: http://www.ccgirasia.com
Mr. Crocker Coulson, President
Tel: +1-646-213-1915 (New York)
Email: crocker.coulson@ccgir.com
